Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Drugs of Today (Barcelona, Spain : 1998)
|
June 1, 2013
Tivozanib: practical implications for renal cell carcinoma and other solid tumors
E M Berge, D W Bowles, T W Flaig, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
November 14, 2019
Targeted therapies for ROS1-rearranged non-small cell lung cancer
T Patil, E Simons, R Mushtaq, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations
K Wang, J D McDermott, A B Schrock, et al.
British Journal of Cancer
|
August 15, 2013
A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours
D W Bowles, W W Ma, N Senzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study
R Kurzrock, D W Bowles, H Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies
J S Ross, L M Gay, K Wang, et al.
Oncogene
|
April 21, 2015
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer
J J Morton, G Bird, S B Keysar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2022
Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
F Griesinger, G Curigliano, M Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2021
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P Grivas, A R Khaki, T M Wise-Draper, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Drugs of Today (Barcelona, Spain : 1998)
|
June 1, 2013
Tivozanib: practical implications for renal cell carcinoma and other solid tumors
E M Berge, D W Bowles, T W Flaig, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
November 14, 2019
Targeted therapies for ROS1-rearranged non-small cell lung cancer
T Patil, E Simons, R Mushtaq, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations
K Wang, J D McDermott, A B Schrock, et al.
British Journal of Cancer
|
August 15, 2013
A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours
D W Bowles, W W Ma, N Senzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study
R Kurzrock, D W Bowles, H Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies
J S Ross, L M Gay, K Wang, et al.
Oncogene
|
April 21, 2015
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer
J J Morton, G Bird, S B Keysar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2022
Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
F Griesinger, G Curigliano, M Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2021
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P Grivas, A R Khaki, T M Wise-Draper, et al.
Page
of 2